Relapse in leprosy and type II reaction in a patient treated with multidrug therapy (MDT)

Recidiva de lepra y reacción tipo II en paciente tratado con poliquimioterapia (PQT)

Published 2014-07-01

Open | Download
PDF (Spanish) FLIP HTML (Spanish)
Issue
Vol. 12 No. 21 (2014)
Section
Artículo Original Producto de Investigación
How to Cite
Relapse in leprosy and type II reaction in a patient treated with multidrug therapy (MDT). (2014). NOVA, 12(21). https://doi.org/10.22490/24629448.1000
doi

https://doi.org/10.22490/24629448.1000
Dimensions
PlumX
license

Licencia Creative Commons

NOVA by http://www.unicolmayor.edu.co/publicaciones/index.php/nova is distributed under a license creative commons non comertial-atribution-withoutderive 4.0 international.

Furthermore, the authors keep their property intellectual rights over the articles.

 

Gina Sofía Montaño Padilla
    Paula Catalina Lancheros González
      Luis Gustavo Celis
        Show authors biography
        Leprosy is a chronic infectious disease endemic to African, Asian, Latin America and South Pacific countries. It is caused by Mycobacterium leprae that manifests itself as varied as areas of hypo or anesthesia, macules hypochromic, with or without neura thickening. On some occasions, after having completed the course of therapy recommended by the World Health Organization, it can recur, showing new clinical lesions or increasing the bacillary index. These features can be confused with erythema nodosum leprosum, characterized by an antigen-antibody reaction that secures a complement through which the immune system combats antigen cells. This text describes a case of recurrence of lepromatous leprosy and lesions compatible with erythema nodosum leprosum after it has been treated with combination chemotherapy.

        Article visits 182 | PDF visits 96

        Downloads

        Download data is not yet available.
        1. Rodríguez G, Pinto R. La Lepra. Imágenes y Conceptos. Mede-llín. Universidad de la Sabana, Universidad de Antioquia; 2007.
        2. Diana N.J. Lockwood & María Da Graca Cunha. Developing new MDT regimens for MB patients; Time to test ROM 12 month regimens globally. Lepr Rev. 2012; 83: 241-244.
        3. Gerzaín Rodríguez Toro, Rafael Pinto García. Mujer Joven con epistaxis, fiebre y nódulos cutáneos, agravados durante su se-gundo embarazo. Cuadernos de Medicina.2007;1(1).
        4. Gerzaín Rodríguez, María Claudia Abaúnza, Elga Vargas, Fernando López. La lepra y el Testículo. Biomédica.2012; 32:13-22.
        5. David M. Scollard. Chemotherapy of leprosy has changed (al-most) everything. Lepr Rev. 2012;83:245-246.
        6. Pocaterra L, Jain S, Reddy R, Muzaffrullah S, Torres O, Suneetha S, et al. Clinical course of erythema nodosum lepro-sum: An 11 year cohort study in Hyderabad, India. Am J Trop Med Hyg. 2006; 74:868-79.
        7. Ministerio de Protección social. Plan estratégico de Colombia para aliviar la carga de la enfermedad y sostener las actividades de control de la lepra. 2010-2015. Bogotá: Gráficas Ducal; 2009.
        8. Organización Panamericana de la Salud (OPS). Fedesalud. Ministerio de Protección social. Guía de Atención Integral de la Lepra. 2010.
        9. Kaimal, S., & Thappa, D. M. Relapse in leprosy. Indian Journal of Dermatology, Venereology, and Leprology.2009; 75(2): 126.
        10. Shen J, Liu M, Zhang J, Su W, Ding G. Relapse in MB leprosy patients treated with 24 months of MDT in south west China: A short report. Lepr Rev. 2006; 77:219-24.
        11. Sowmya, K., & Devinder, M. Relapse in leprosy. Indian J Lepr.2009; 75:126-135.
        12. Steven L. Walker, Michael F.R. Waters & Diana N.J. Loc-kwood. The Role of Thalidomide in the management of erythema nodosum leprosum. Lepr Rev. 2007;78:197-215.
        13. Zhang, F. R., Huang, W., Chen, S. M., Sun, L. D., Liu, H., Li, Y.,... & Yu, J. P. Genome wide association study of le-prosy. New England Journal of Medicine. 2009; 361(27): 2609-2618.
        14. Vasudha A. Belgaumkar, Neetar R. Gokhale, Pradeep M. Ma-hajan, Renu Bharadwaj, Dakshayani P Pandit & Shantanu Deshpande. Lepr Rev. 2007;78: 223-230.
        15. Harminder Singh, Bithika Nel, Vibek Dey, Pawan Tiwari & Naveen Dulhani. Lepr Rev. 2011; 82:17-24.
        16. Mitranna Poojabylaiah, Ramesh Bhat Marne, Rajina Varikkodan, Nandakishore Bala, Sukumar Dandakeri & Jacintha Martis. Relapses in multibacillary leprosy patients after Multi-drug therapy. Lepr Rev. 2008; 79: 320-324.
        17. Laura c Rodrigues, Diana J.N Lockwood. Leprosy now: Epi-demiology, progress, challenges, and research gaps. The Lancet Infectious Diseases.2011; 6:464-470.
        18. Walker, Stephen L.; Peter Nicholls; Sushmita Dhakal; Ra-chel Hawksworth; Murdo MacDonald,; Kishori Mahat; et al. A Comparison of the Change in Clinical Severity Scale Score and a Retrospective Physician Assessment of Neurological Outcome in Individuals with Leprosy Asso-ciated Nerve Function Impairment after Treatment with Corticosteroids. Leprosy Review. British Leprosy Relief Association. 2012.
        19. Alter, A., Alcais, A., Abel, L., & Schurr, E. Leprosy as a genetic model for susceptibility to common infectious diseases. Human genetics. 2008;123(3): 227-235.
        20. O.A. Chichava, L. Ariza, A.R. Oliveira, A.C. Ferreira, L.F. Marques Da Silva, J.C. Barbosa, A.N. Ramos JR & J. Heuke-lbach. Reasons for interrupting multidrug therapy against leprosy: The patients´ point of view. Lepr Rev. 2011; 82:78-79.
        21. Maria Pena, Annemieke Geluk, Jolien J. Van Der Ploeg Van Schip, Kees L.M.C. Franken, Rahul Sharma & Richard Trauman. Cytokine responses to Mycobacterium leprae unique proteins differentiate between Mycobacterium leprae infected and naive armadillos. Lepr Rev. 2011; 82: 422 - 431.
        22. ----------------------------------------------------------------------------
        23. DOI: http://dx.doi.org/10.22490/24629448.1000
        Tutorials

        Autors:

        How send article?

        Evaluator pair

        How to evaluate an article?

        Information

        Keywords

        Google Scholar profile

        Is part of
         

        Current Issue

        Sistema OJS 3.4.0.5 - Metabiblioteca |